The population of adult cancer survivors is increasing over time and they are at risk of developing recurrent and secondary cancers, even years after completion of treatment. Post-treatment care of survivors is increasingly the responsibility of primary care providers. Surveillance for recurrence and screening for secondary malignancies related to treatment depend largely on the primary malignancy, treatment regimen, and presence of a hereditary cancer syndrome, such as a BRCA mutation. This article presents surveillance strategies for the most common malignancies.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.mcna.2017.06.010 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!